A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia
Clinical trial NCT02055157 · COMPLETED
Trial details
- NCT number
- NCT02055157
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-13
- Primary completion
- 2017-10-02
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.